Research / ACA / Fundamental state Inspectable configuration
State dimensions Filing 0001739445-22-000129 General Corporate
Debt relative to revenue 75th Own-history percentile · N=16
Evidence method Level · gp.fundamentals.debt_to_revenue
115.35% · OPTIONAL · VALID
Capex intensity 100th Own-history percentile · N=15
Evidence method Level · gp.fundamentals.capex_revenue_ratio
5.46% · OPTIONAL · VALID
Operating cash generation 53th Own-history percentile · N=15
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
11.82% · OPTIONAL · VALID
Revenue growth 25th Own-history percentile · N=12
Evidence method Yoy · gp.fundamentals.revenue
8.01% · CORE · VALID
Inventory pressure 31th Own-history percentile · N=16
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
54.45% · OPTIONAL · VALID
Operating margin 50th Own-history percentile · N=16
Evidence method Level · gp.fundamentals.operating_margin
8.11% · CORE · VALID
SBC intensity 63th Own-history percentile · N=16
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.89% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 28 states Self-history eligible
Sep 30, 2021 7/7 normalized Level 3 Dec 31, 2021 7/7 normalized Level 3 Mar 31, 2022 7/7 normalized Level 3 Jun 30, 2022 7/7 normalized Level 3 Sep 30, 2022 7/7 normalized Level 3 Dec 31, 2022 7/7 normalized Level 3 Mar 31, 2023 7/7 normalized Level 3 Jun 30, 2023 7/7 normalized Level 3 Sep 30, 2023 7/7 normalized Level 3 Dec 31, 2023 7/7 normalized Level 3 Mar 31, 2024 7/7 normalized Level 3 Jun 30, 2024 7/7 normalized Level 3 Sep 30, 2024 7/7 normalized Level 3 Dec 31, 2024 7/7 normalized Level 3 Mar 31, 2025 7/7 normalized Level 3 Jun 30, 2025 7/8 normalized Level 3 Sep 30, 2025 7/8 normalized Level 3 Dec 31, 2025 7/8 normalized Level 3 Mar 31, 2026 7/8 normalized Level 3 Jun 30, 2026 7/8 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 116.03%
Current 115.35%
Delta -0.68% Capex Intensity Increased
Previous 4.48%
Current 5.46%
Delta 0.99% Cash Generation Decreased
Previous 14.38%
Current 11.82%
Delta -2.56% Growth Decreased
Previous 17.03%
Current 8.01%
Delta -9.01% Inventory Pressure Increased
Previous 49.09%
Current 54.45%
Delta 5.36% Profitability Decreased
Previous 9.49%
Current 8.11%
Delta -1.38% Sbc Intensity Decreased
Previous 0.95%
Current 0.89%
Delta -0.05% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.